Jump to ContentJump to Main Navigation
Show Summary Details

Biological Chemistry

Editor-in-Chief: Brüne, Bernhard

Editorial Board Member: Buchner, Johannes / Lei, Ming / Ludwig, Stephan / Sies, Helmut / Turk, Boris / Wittinghofer, Alfred


SCImago Journal Rank (SJR) 2015: 1.607
Source Normalized Impact per Paper (SNIP) 2015: 0.751
Impact per Publication (IPP) 2015: 2.609

Online
ISSN
1437-4315
See all formats and pricing

 


 
 

Select Volume and Issue

Issues

30,00 € / $42.00 / £23.00

Get Access to Full Text

Maintenance of serological memory

Jens Wrammert1 / Rafi Ahmed2

1Emory Vaccine Center and Department of Microbiology and Immunology, Emory University School of Medicine, Atlanta, GA 30322, USA

2Emory Vaccine Center and Department of Microbiology and Immunology, Emory University School of Medicine, Atlanta, GA 30322, USA

Corresponding author

Citation Information: Biological Chemistry. Volume 389, Issue 5, Pages 537–539, ISSN (Online) 14374315, ISSN (Print) 1431-6730, DOI: https://doi.org/10.1515/BC.2008.066, March 2008

Publication History

Published Online:
2008-03-27

Abstract

Long-lived plasma cells are key to maintaining long-term humoral immunity after infection or vaccination. Some vaccines and/or infections induce antibody levels that remain stable for the life of the individual. However, the mechanism whereby these long-lived plasma cells are maintained over long periods of time remains an open question. Furthermore, given a finite number of sustainable plasma cells within the bone marrow, it is also unclear how space for newly induced plasma cells is generated without compromising the pre-existing repertoire. Here we review the current understanding of these important issues.

Keywords: antibodies; humoral immunity; plasma cells; vaccination

Citing Articles

Here you can find all Crossref-listed publications in which this article is cited. If you would like to receive automatic email messages as soon as this article is cited in other publications, simply activate the “Citation Alert” on the top of this page.

[1]
M. Habiela, J. Seago, E. Perez-Martin, R. Waters, M. Windsor, F. J. Salguero, J. Wood, B. Charleston, and N. Juleff
Journal of General Virology, 2014, Volume 95, Number Pt_11, Page 2329
[2]
Mohey Eldin El Shikh, Maciej Kmieciak, Masoud H Manjili, Andras K Szakal, Costantino Pitzalis, and John G Tew
Human Vaccines & Immunotherapeutics, 2013, Volume 9, Number 11, Page 2434
[3]
Franziska Zabel, Thomas M. Kündig, and Martin F. Bachmann
Current Opinion in Virology, 2013, Volume 3, Number 3, Page 357
[4]
O. Winter, K. Moser, E. Mohr, D. Zotos, H. Kaminski, M. Szyska, K. Roth, D. M. Wong, C. Dame, D. M. Tarlinton, H. Schulze, I. C. M. MacLennan, and R. A. Manz
Blood, 2010, Volume 116, Number 11, Page 1867
[5]
Rachel M. Stenger, Mieke Smits, Betsy Kuipers, Jacqueline van Gaans-van den Brink, Martien Poelen, Claire J.P. Boog, and Cécile A.C.M. van Els
Vaccine, 2010, Volume 28, Number 40, Page 6637
[6]
Pedro C. Rodriguez, Ileana Gonzalez, Adys Gonzalez, Janet Avellanet, Armando Lopez, Rolando Perez, Agustin Lage, and Enrique Montero
Vaccine, 2008, Volume 26, Number 36, Page 4647
[7]
Susana Lousada-Dietrich, Prajakta S. Jogdand, Søren Jepsen, Vera V. Pinto, Sisse B. Ditlev, Michael Christiansen, Severin Olesen Larsen, Christopher B. Fox, Vanitha S. Raman, Randall F. Howard, Thomas S. Vedvick, Gregory Ireton, Darrick Carter, Steven G. Reed, and Michael Theisen
Vaccine, 2011, Volume 29, Number 17, Page 3284
[8]
D. G. Koutsonanos, M. del Pilar Martin, V. G. Zarnitsyn, J. Jacob, M. R. Prausnitz, R. W. Compans, and I. Skountzou
Journal of Infectious Diseases, 2011, Volume 204, Number 4, Page 582
[9]
Andre Tanel, Simone G Fonseca, Bader Yassine-Diab, Rebeka Bordi, Joumana Zeidan, Yu Shi, Clarisse Benne, and Rafick-Pierre Sékaly
Expert Review of Vaccines, 2009, Volume 8, Number 3, Page 299
[10]
Dennis R. Burton and Pascal Poignard
Nature, 2009, Volume 458, Number 7238, Page 584

Comments (0)

Please log in or register to comment.